International Assets Investment Management LLC Purchases 10,753 Shares of Abrdn Life Sciences Investors (NYSE:HQL)

International Assets Investment Management LLC boosted its holdings in Abrdn Life Sciences Investors (NYSE:HQL) by 3,424.5% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 11,067 shares of the company’s stock after buying an additional 10,753 shares during the quarter. International Assets Investment Management LLC’s holdings in Abrdn Life Sciences Investors were worth $149,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. Janney Montgomery Scott LLC raised its stake in shares of Abrdn Life Sciences Investors by 1.7% during the third quarter. Janney Montgomery Scott LLC now owns 72,249 shares of the company’s stock valued at $901,000 after acquiring an additional 1,220 shares during the last quarter. Shaker Financial Services LLC increased its holdings in Abrdn Life Sciences Investors by 2.1% in the third quarter. Shaker Financial Services LLC now owns 66,528 shares of the company’s stock valued at $830,000 after purchasing an additional 1,342 shares during the period. 180 Wealth Advisors LLC lifted its holdings in Abrdn Life Sciences Investors by 5.3% during the 3rd quarter. 180 Wealth Advisors LLC now owns 114,724 shares of the company’s stock worth $1,431,000 after buying an additional 5,725 shares during the period. Atlas Wealth LLC grew its position in shares of Abrdn Life Sciences Investors by 90.7% in the 3rd quarter. Atlas Wealth LLC now owns 24,969 shares of the company’s stock valued at $311,000 after buying an additional 11,879 shares during the last quarter. Finally, Thomas J. Herzfeld Advisors Inc. increased its stake in shares of Abrdn Life Sciences Investors by 13.0% in the third quarter. Thomas J. Herzfeld Advisors Inc. now owns 116,904 shares of the company’s stock valued at $1,458,000 after buying an additional 13,414 shares during the period. 32.21% of the stock is currently owned by institutional investors and hedge funds.

Insider Buying and Selling

In other news, major shareholder Saba Capital Management, L.P. purchased 81,738 shares of the business’s stock in a transaction on Thursday, April 18th. The shares were acquired at an average price of $12.80 per share, with a total value of $1,046,246.40. Following the completion of the transaction, the insider now owns 2,694,511 shares of the company’s stock, valued at approximately $34,489,740.80. The purchase was disclosed in a filing with the SEC, which can be accessed through the SEC website. Insiders bought 104,689 shares of company stock valued at $1,346,958 over the last quarter. Insiders own 10.06% of the company’s stock.

Abrdn Life Sciences Investors Stock Performance

Shares of HQL opened at $12.97 on Monday. The business has a 50-day moving average of $13.47 and a 200-day moving average of $13.11. Abrdn Life Sciences Investors has a 1 year low of $11.34 and a 1 year high of $14.37.

Abrdn Life Sciences Investors Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, March 28th. Stockholders of record on Thursday, February 22nd were given a dividend of $0.39 per share. The ex-dividend date was Wednesday, February 21st. This is a boost from Abrdn Life Sciences Investors’s previous quarterly dividend of $0.30. This represents a $1.56 annualized dividend and a dividend yield of 12.03%.

About Abrdn Life Sciences Investors

Abrdn Life Sciences Investors is a closed-ended equity mutual fund launched and managed by abrdn Inc The fund invests in public equity markets across the globe. It seeks to invest in stocks of companies operating in the life sciences sector, including the biotechnology, pharmaceutical, diagnostics, managed healthcare, medical equipment, hospitals, healthcare information technology and services, devices and supplies industries, and in agriculture and environmental management industries.